Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

PFE

Pfizer Inc

Apr 24 • 01:49PM ET

26.93

+0.26 0.97 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Today, 7:05 AMPfizer, Bristol Myers Squibb partner with Mark Cuban Cost Plus Drug Company to sell Eliquis directly to U.S. patients from April 27, 2026

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN-D

| Held by: VTI VOO IVV SPY VTV XLV VYM DVY VHT FDL

Index	S&P 500	P/E	19.87	EPS (ttm)	1.36	Insider Own	0.07%	Shs Outstand	5.69B	Perf Week	-2.29%
Market Cap	153.19B	Forward P/E	9.57	EPS next Y	2.81	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	-1.28%
Enterprise Value	207.31B	PEG	-	EPS next Q	0.72	Inst Own	67.07%	Short Float	2.33%	Perf Quarter	4.99%
Income	7.75B	P/S	2.45	EPS this Y	-8.08%	Inst Trans	0.13%	Short Ratio	3.17	Perf Half Y	8.94%
Sales	62.58B	P/B	1.77	EPS next Y	-4.90%	ROA	3.67%	Short Interest	132.47M	Perf YTD	8.15%
Book/sh	15.21	P/C	11.27	EPS next 5Y	-8.99%	ROE	8.87%	52W High	28.75 -6.31%	Perf Year	18.22%
Cash/sh	2.39	P/FCF	16.88	EPS past 3/5Y	-37.19% -3.57%	ROIC	5.15%	52W Low	21.97 22.58%	Perf 3Y	-32.52%
Dividend Est.	1.75 (6.52%)	EV/EBITDA	8.60	Sales past 3/5Y	-14.56% 8.48%	Gross Margin	66.23%	Volatility	1.79% 1.95%	Perf 5Y	-30.34%
Dividend TTM	1.72 (6.39%)	EV/Sales	3.31	EPS Y/Y TTM	-3.74%	Oper. Margin	27.99%	ATR (14)	0.56	Perf 10Y	-14.59%
Dividend Ex-Date	May 08, 2026	Quick Ratio	0.87	Sales Y/Y TTM	-1.65%	Profit Margin	12.38%	RSI (14)	46.26	Recom	2.50
Dividend Gr. 3/5Y	2.23% 2.37%	Current Ratio	1.16	EPS Q/Q	-509.90%	SMA20	-1.71%	Beta	0.32	Target Price	28.90
Payout	126.85%	Debt/Eq	0.78	Sales Q/Q	-1.16%	SMA50	-1.03%	Rel Volume	0.90	Prev Close	26.67
Employees	75000	LT Debt/Eq	0.74	Earnings	May 05 BMO	SMA200	4.98%	Avg Volume	41.79M	Price	26.93
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.42% 4.20%	Trades		Volume	25,562,286	Change	0.97%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-02-26	Upgrade	Argus	Hold → Buy	$35
Feb-25-26	Initiated	RBC Capital Mkts	Underperform	$25
Feb-20-26	Initiated	Barclays	Underweight	$25
Feb-12-26	Downgrade	Daiwa Securities	Outperform → Neutral	$27
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50

Show Previous Ratings

Today 01:34PM	Bristol Myers, Pfizer Bring Eliquis to Cost Plus at $345 Monthly (GuruFocus.com)
11:00AM	Eli Lilly's new GLP-1 pill vs. Wegovy, JPMorgan initiates coverage on Hims (Yahoo Finance Video)
06:59AM	Bristol Myers Squibb and Pfizer to Make Eliquis (apixaban) Available via Mark Cuban Cost Plus Drug Company (Business Wire)
Apr-23-26 05:49PM	Regeneron Shares Up on Trump Drug Pricing Deal (Barrons.com)
02:27AM	Richest countries in 2026: New measure of wealth pushes France and Germany out of top ten (Euronews)
04:45PM	Loading…
Apr-22-26 04:45PM	Pfizer Declares Second-Quarter 2026 Dividend (Business Wire)
11:01AM	Pfizer CFO Dave Denton on Oncology, Obesity, and Pfizers Next Growth Cycle (NYSE)
Apr-21-26 12:23PM	Eli Lilly eyes Kelonia Therapeutics in $7B deal with $3.25B to be paid up front. How to invest early to grow your wealth (Moneywise)
11:51AM	Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026 (Business Wire)
06:29AM	Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy (Pharmaceutical Business Review)
Apr-20-26 10:47AM	Novo's Once-Daily Sickle Cell Pill Hits Milestone. A Smaller Rival Is Sinking 24%. (Barrons.com)
06:45AM	U.S. FDA Grants Priority Review to sBLA for PADCEV + Keytruda as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility (PR Newswire)
Apr-17-26 04:13PM	Why Is Abbott Stock Trending Lower? (Trefis)
Apr-13-26 11:43AM	How Eli Lilly Stock Rises To $2,000 (Trefis)
Apr-11-26 08:01PM	How Pfizer's Oncology Portfolio Is Shaping Up Before Q1 Results (Quartz)
08:11PM	Loading…
Apr-10-26 08:11PM	Here's How AMRX Is Tapping GLP-1 Demand Through Manufacturing (Quartz)
Apr-09-26 10:00AM	Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders (Business Wire)
Apr-08-26 12:44PM	Gilead Agrees $5 Billion Tubulis Acquisition To Expand Cancer Drug Pipeline (GuruFocus.com)
Apr-07-26 05:47PM	The $190 Billion 'Diabesity' Market Is Set to Explode. Lilly and Novo Face These Stock Catalysts. (Barrons.com)
Apr-02-26 04:05PM	Trump slaps steep tariffs on patented drug imports (Supply Chain Dive)
11:37AM	Boost Pfizer's Already Hefty 6% Dividend Yield With A Covered Call (Investor's Business Daily)
08:01AM	JNJ Stocks 60% Breakout: Why Wall Street is Torn (Trefis)
Apr-01-26 04:07PM	Why 2026 Is Biotech's Comeback Year (Barrons.com)
04:05PM	Oric Shares Fall 40% as Cancer-Drug Data Falls Short of Expectations (The Wall Street Journal)
10:02AM	Oric Pharma Misses The 'Best-In-Class' Boat Vs. Pfizer - And Plunges (Investor's Business Daily)
09:30AM	Pfizer Pulls Back From South San Francisco (GuruFocus.com)
04:00AM	Will Pfizers Lyme disease gamble pay off or set the space back? (Pharma Voice)
Mar-31-26 03:45PM	$2 Billion Bayer Verdict: What the Roundup Decision Means for MAHA (Exec Edge)
Mar-30-26 10:44AM	Pharma Stocks Pfizer, GSK Offer Defensive Plays in an Uncertain Market: Charts (Barrons.com)
09:37AM	Eli Lilly Ramps Up AI Ambitions With This $2.8 Billion Deal. What It Means for the Stock. (Barrons.com)
09:17AM	Loading…
09:17AM	Eli Lilly Ramps Up AI Ambitions With This $2.8 Billion Deal. The Stock Rises. (Barrons.com)
02:03AM	Connecting Excellence Group appoints chief performance and growth officer (Proactive)
Mar-27-26 11:40AM	Consecutive approvals of Opdivo for Hodgkins lymphoma to boost sales growth (Clinical Trials Arena)
Mar-26-26 01:30AM	22 S&P 500 Stocks Yield More Than 5%. 6 That Are Worth Buying. (Barrons.com)
Mar-24-26 11:02AM	Pfizer CFO Dave Denton Highlights Firms Recent Oncology Milestones (NYSE)
10:39AM	Pfizer Reports 73% Lyme Vaccine Efficacy as Trial Results Complicate Outlook (GuruFocus.com)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts (Business Wire)
05:57AM	Immutrin raises $87M to advance drug for progressive heart disease (BioPharma Dive)
Mar-23-26 02:31PM	Pfizer-Valneva Lyme disease vaccine falls short as low cases skew results (Clinical Trials Arena)
01:00PM	Stocks Rise, Oil Falls as Trump Eases Iran Threats: Markets Wrap (Bloomberg)
12:46PM	Pfizer's Lyme Vaccine Shows Strong Efficacy, but Misses Mark in Study (The Wall Street Journal)
09:54AM	Mixed results for Lyme disease vaccine hit Valneva shares (AFP)
08:06AM	Pfizer, Valneva to seek approval of Lyme disease vaccine despite mixed study results (BioPharma Dive)
08:00AM	Telescope Innovations Announces Expansion of Consulting Role for Dr. Joel M. Hawkins, Industry Leader in Process Chemistry Automation (TMX Newsfile)
07:07AM	Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial (MarketWatch)
07:02AM	Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial (The Wall Street Journal)
06:45AM	Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial (Business Wire)
Mar-22-26 09:00PM	IP Group PLC (IPZYF) Full Year 2025 Earnings Call Highlights: Strong NAV Growth Amid Market ... (GuruFocus.com)
Mar-20-26 04:30PM	Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC (Business Wire)
Mar-19-26 09:47AM	ImmuPharma, Ilika, Coinsilium Group, IP Group, Team Internet Group - Small Cap Week in Review (Proactive)
07:37AM	Pfizer aims for wider use of PARP drug in prostate cancer with new data (BioPharma Dive)
07:30AM	The $3.4 billion lesson Big Pharma needs to learn: its shelved drugs could save millions of patients (Fortune)
06:45AM	TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer (Business Wire)
Mar-18-26 05:00PM	Valneva SE (INRLF) Full Year 2025 Earnings Call Highlights: Strategic Advances Amid Financial ... (GuruFocus.com)
02:29PM	Analysis-TrumpRx lists many medicines at prices higher than paid in UK (Reuters)
Mar-17-26 03:01PM	Pfizer Reports Positive Mid-Stage Breast Cancer Trial Results (GuruFocus.com)
07:56AM	Bicycle to lay off 30% of staff, pivot away from Padcev challenger (BioPharma Dive)
07:15AM	Pfizers Ibrance successor moves forward with new study data (BioPharma Dive)
06:45AM	Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer (Business Wire)
05:53AM	Empire Metals, Atlantic Lithium, ImmuPharma, IP Group, Light Science Technologies, ATOME (Proactive)
Mar-16-26 11:38AM	IP Group CEO on 2025 highlights, NAV uplift, Pfizer royalties & capital allocation (Proactive)
Mar-15-26 05:05PM	Man's dog was riddled with tumors and dying. He used ChatGPT to design a custom cancer vaccine, stunning researchers (Moneywise)
Mar-13-26 11:38PM	Ecuador trade deal: Trump administration targets lower food and tech levies (Investing.com)
07:54AM	GSKs RSV vaccine wins broader FDA clearance (BioPharma Dive)
Mar-12-26 10:28AM	Starboard Value Is Betting Big on This Blue-Chip Dividend Stock. Should You? (Barchart)
07:00AM	The Best Covered Call Strategy to Trade High-Yielding Pfizer Stock and Earn Extra Income (Barchart)
Mar-11-26 12:41PM	Be nimble, be ready: how to tackle regulatory uncertainty in clinical trials (Clinical Trials Arena)
Mar-10-26 04:20PM	Why BridgeBio Leapfrogged Its 50-Day Line On Pfizer's Patent Shake-Up (Investor's Business Daily)
03:00PM	BioNTech SE (BNTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue Challenges (GuruFocus.com)
02:49PM	BridgeBio's Rare-Disease Pipeline Sparks Growth Buzz (Benzinga)
09:24AM	BioNTech Reports Earnings. That's Not Why the Stock Is Down 17%. (Barrons.com)
08:40AM	BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture (Benzinga)
08:19AM	BioNTechs Founding Duo Will Leave to Start New mRNA Firm (Bloomberg)
07:18AM	BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. (Barrons.com)
07:00AM	Xenon hits a home run in epilepsy; FDA restarts review of Duchenne cell therapy (BioPharma Dive)
Mar-09-26 02:14PM	Roches oral SERD fails in Phase III breast cancer trial (Clinical Trials Arena)
01:42PM	Factbox-Global drugmakers rush to boost US presence as tariff threat looms (Reuters)
12:22PM	Why Is Olema Pharmaceuticals Stock Dropping On Monday? (Benzinga)
10:21AM	Roche Shares Drop Up to 7.5% After Breast Cancer Pill Misses Trial Goal (GuruFocus.com)
08:19AM	Roches prized breast cancer pill fails closely watched study (BioPharma Dive)
07:42AM	Stocks to Watch Monday: Moderna, Live Nation, Pfizer, Hims & Hers (The Wall Street Journal)
06:45AM	Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis (Business Wire)
05:44AM	Roche Shares Fall After Breast-Cancer Treatment Misses Goal in Late-Stage Study (The Wall Street Journal)
05:43AM	Stocks to Watch Monday: Lamb Weston, Carnival, Pfizer, Hims & Hers (The Wall Street Journal)
Mar-08-26 04:49PM	These 8 drugs could help fight dementia - and they're already on the market (MarketWatch)
Mar-07-26 12:26PM	C4 Therapeutics Maps Accelerated Approval Path for Myeloma Drug Cemsidomide at TD Cowen Conference (MarketBeat)
Mar-06-26 11:30AM	AbbVie (ABBV) Up 6.1% Since Last Earnings Report: Can It Continue? (Zacks)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
08:14AM	China Clears Weight-Loss Shot As Pfizer Enters Crowded Market (Benzinga)
05:13AM	Pfizer nabs first obesity approval; Alnylam, Tenaya search for heart drugs (BioPharma Dive)
03:53AM	BridgeBio Pharma Talks Atrubie Momentum, Phase 3 Wins as Tafamidis IP Trial Looms (MarketBeat)
Mar-05-26 11:30AM	Pfizer (PFE) Down 0.6% Since Last Earnings Report: Can It Rebound? (Zacks)
08:45AM	Can Pfizer Reignite Growth Amid COVID Declines and Patent Expirations? (Zacks)
Mar-04-26 08:54PM	Argus Turns Bullish on Pfizer (PFE), Highlights GLP-1 and Oncology Pipeline (Insider Monkey)
10:36AM	Arvinas Highlights Growing Phase 1 Pipeline, Near-Term Catalysts at TD Cowen Healthcare Conference (MarketBeat)
08:55AM	NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals (PR Newswire)
12:48AM	Pfizer Inc. (PFE) and Astellas Report Positive Phase 3 EV-304 Results for PADCEV Plus Keytruda in Bladder Cancer (Insider Monkey)
Mar-03-26 07:24PM	Analyst Report: ICU Medical, Inc. (Morningstar Research)
03:35PM	The Dividend Safe Harbor: 2 Stocks to Watch (MarketBeat)
09:10AM	Immunology, Neuroscience Step Up as Key Growth Engines for J&J (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SAHNI PAYAL	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	82,816	Feb 27 06:35 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 25 '26	Option Exercise	33.82	122,907	4,156,715	282,186	Feb 27 06:35 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25 '26	Option Exercise	33.82	17,558	593,812	29,744	Feb 27 06:35 PM
BOURLA ALBERT	Chairman & CEO	Feb 25 '26	Option Exercise	33.82	491,626	16,626,791	864,215	Feb 27 06:34 PM
Fonseca Lidia	Executive Vice President	Feb 25 '26	Option Exercise	33.82	56,888	1,923,952	101,579	Feb 27 06:34 PM
McDermott Michael	Executive Vice President	Feb 25 '26	Option Exercise	33.82	37,925	1,282,624	114,534	Feb 27 06:34 PM
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM

Open in Screener

KMX

Carmax Inc

Apr 24 • 01:49PM ET

37.90

-0.65 -1.67 %

Consumer Cyclical • Auto & Truck Dealerships • USA • NYSE

Peers: AN LAD PAG SAH ABG GPI TSLA GM F HOG

| Held by: IJR VTI VB VBR AVUV VXF IJS SPSM CALF SLYV

Index	-	P/E	23.81	EPS (ttm)	1.59	Insider Own	4.14%	Shs Outstand	141.80M	Perf Week	-7.28%
Market Cap	5.38B	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	135.94M	Perf Month	-9.49%
Enterprise Value	23.40B	PEG	-	EPS next Q	0.95	Inst Own	103.47%	Short Float	11.10%	Perf Quarter	-18.11%
Income	247.29M	P/S	0.19	EPS this Y	-19.52%	Inst Trans	-1.16%	Short Ratio	4.34	Perf Half Y	-13.58%
Sales	27.75B	P/B	0.91	EPS next Y	-	ROA	0.91%	Short Interest	15.09M	Perf YTD	-1.90%
Book/sh	41.53	P/C	7.52	EPS next 5Y	-0.29%	ROE	4.08%	52W High	71.99 -47.35%	Perf Year	-42.29%
Cash/sh	5.04	P/FCF	4.33	EPS past 3/5Y	-17.96% -18.02%	ROIC	1.04%	52W Low	30.26 25.26%	Perf 3Y	-44.97%
Dividend Est.	-	EV/EBITDA	24.15	Sales past 3/5Y	-3.76% 6.67%	Gross Margin	11.02%	Volatility	4.58% 4.81%	Perf 5Y	-71.08%
Dividend TTM	-	EV/Sales	0.84	EPS Y/Y TTM	-50.32%	Oper. Margin	2.18%	ATR (14)	2.10	Perf 10Y	-28.78%
Dividend Ex-Date	-	Quick Ratio	0.49	Sales Y/Y TTM	-1.64%	Profit Margin	0.89%	RSI (14)	37.92	Recom	3.20
Dividend Gr. 3/5Y	- -	Current Ratio	2.20	EPS Q/Q	-246.39%	SMA20	-9.16%	Beta	1.20	Target Price	37.00
Payout	0.00%	Debt/Eq	3.18	Sales Q/Q	-1.29%	SMA50	-10.05%	Rel Volume	0.48	Prev Close	38.55
Employees	27796	LT Debt/Eq	3.04	Earnings	Apr 14 BMO	SMA200	-18.89%	Avg Volume	3.48M	Price	37.90
IPO	Feb 04, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	48.93% 4.02%	Trades		Volume	1,129,279	Change	-1.67%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-15-26	Resumed	BofA Securities	Underperform	$40
Nov-12-25	Initiated	Barclays	Underweight	$28
Nov-10-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$35
Nov-07-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Nov-07-25	Downgrade	Needham	Buy → Hold
Nov-06-25	Downgrade	William Blair	Outperform → Mkt Perform
Nov-06-25	Downgrade	The Benchmark Company	Buy → Hold
Nov-06-25	Downgrade	JP Morgan	Neutral → Underweight	$30
Oct-07-25	Downgrade	Stephens	Overweight → Equal-Weight	$42
Sep-29-25	Downgrade	Seaport Research Partners	Buy → Neutral
Sep-26-25	Downgrade	Oppenheimer	Outperform → Perform
Sep-26-25	Downgrade	Evercore ISI	Outperform → In-line	$52
Sep-25-25	Downgrade	Wedbush	Outperform → Neutral
Aug-06-25	Upgrade	JP Morgan	Underweight → Neutral	$58
Jul-17-25	Initiated	The Benchmark Company	Buy	$75
Jul-01-25	Resumed	Morgan Stanley	Overweight	$80
May-19-25	Resumed	Wedbush	Outperform	$90
Mar-26-25	Upgrade	Stephens	Equal-Weight → Overweight	$86 → $90
Feb-06-25	Upgrade	Evercore ISI	In-line → Outperform	$90 → $110
Dec-05-24	Initiated	Stephens	Equal-Weight	$86

Show Previous Ratings

Apr-17-26 08:13AM	CarMax prices start to fall as turnaround plan begins (Wards Auto)
Apr-15-26 09:47AM	Cloudflare upgraded, SolarEdge downgraded: Wall Street's top analyst calls (The Fly)
08:00AM	CarMax cut its prices to bring back buyers. It just reported a $121 million loss (Moneywise)
03:01AM	CarMax Inc (KMX) Q4 2026 Earnings Call Highlights: Navigating Challenges with Strategic Adjustments (GuruFocus.com)
Apr-14-26 04:46PM	CarMax, Inc. Q4 2026 Earnings Call Summary (Moby) -15.12%
02:10PM	Loading…
02:10PM	Tesla stock upgraded, CarMax Q4 earnings disappoint Wall Street (Yahoo Finance Video)
01:23PM	Why CarMax Stock Is Sinking Despite Earnings Beat (Investor's Business Daily)
12:44PM	CarMax Shares Drop 12% As Profit Per Vehicle Set To Decline (GuruFocus.com)
11:11AM	CarMax Drops as Investors Underwhelmed by Revival Strategy (Bloomberg)
07:32AM	CarMax beats FQ4 forecasts, flags $141mn goodwill charge; shares dip (Investing.com)
07:23AM	CarMax Swings to Loss After Cutting Prices to Bring Back Shoppers (The Wall Street Journal)
07:09AM	CarMax: Fiscal Q4 Earnings Snapshot (Associated Press)
07:04AM	CarMax Stock Sinks After Earnings. New CEO Has Work to Do. (Barrons.com)
06:50AM	CarMax Reports Fourth Quarter and Fiscal Year 2026 Results (Business Wire)
06:00AM	Morning Brief: Goldman rakes it in, but issues a warning (Yahoo Finance)
04:57AM	Loading…
04:57AM	JPMorgan, Citi and Wells Fargo deliver results as earnings season gathers speed (MarketWatch)
04:11AM	Stock Market Today: Dow, S&P 500 and Nasdaq set to hold near record highs as earnings season ramps up with JPMorgan results on tap (MarketWatch)
Apr-09-26 04:51PM	CarMax Will Add Two Board Members After Talks With Activist Investor Starboard (The Wall Street Journal)
04:15PM	CarMax Announces William Cobb and Jim Kessler to Join the Board (Business Wire)
Apr-06-26 11:16AM	Carvana Stock Doubled Last Year. Why This Analyst Isn't Bullish Anymore. (Barrons.com)
Apr-01-26 09:30AM	CARMAX CELEBRATES 22nd CONSECUTIVE YEAR AS ONE OF FORTUNE MAGAZINE'S 100 BEST COMPANIES TO WORK FOR (GlobeNewswire)
Mar-27-26 07:15AM	New CarMax CEO Barr looks to tech for better UX (Wards Auto)
Mar-26-26 04:37PM	Stock traders are wary of this market - and retail investors should be too (MarketWatch)
Mar-19-26 05:00PM	CarMax Announces Fourth Quarter Conference Call (Business Wire)
04:12PM	These charts suggest the bears aren't done with the stock market yet (MarketWatch)
Mar-18-26 11:45AM	CarMax appoints Keith Barr as CEO (Wards Auto)
Mar-13-26 08:44PM	Oracle Has More Resilience Amid AI Pressures, Says Analyst. Plus, CarMax, Rivian, and More Stocks. (Barrons.com)
Mar-12-26 06:40PM	The S&P 500 just broke a major support. Another 10% decline is likely. (MarketWatch)
Mar-11-26 04:20PM	Investor Starboard Sees CarMax Upside as Barr Takes Helm (Transport Topics)
02:30PM	Starboard Builds $350 Million Stake in CarMax, Seeks Board Seats (GuruFocus.com)
01:40PM	Loading…
01:40PM	Starboard Takes $350 Million CarMax Stake, Seeks Board Seats (Bloomberg)
01:01PM	An Important Investor Has an Idea for CarMax: Charge Less for Used Cars (Investopedia)
11:29AM	Falling prices steer US buyers toward used electric vehicles (Reuters)
10:35AM	CarMax Issues Statement on Engagement With Starboard Value (Business Wire)
09:58AM	CarMax Stock Edges Higher as Activist Takes Stake, Says New CEO Must 'Move Quickly' (Barrons.com)
09:34AM	Activist Starboard Pushes for Change at CarMax (The Wall Street Journal)
09:17AM	CarMax Stock: Auto Business Activist Investor Takes Stake (Investor's Business Daily)
08:00AM	Starboard Delivers Letter to CarMax (Business Wire)
Mar-06-26 10:02AM	Will Carvana's Fixed Cost Leverage Drive Its EBITDA Margin? (Zacks)
09:52AM	Will Vertical Integration Strengthen Carvana's Prospects? (Zacks)
Mar-05-26 08:03AM	Carvana's Rough Start to 2026 Post Stellar 2025: How to Play the Stock (Zacks)
Mar-04-26 08:10AM	GM merging its CPO dealer sales program with CarBravo (Wards Auto)
Mar-03-26 09:40AM	Should Value Investors Buy CarMax (KMX) Stock? (Zacks)
Feb-27-26 10:36AM	CarMax Launches First-of-Its-Kind Car Shopping and Selling Experience in ChatGPT App Store (GlobeNewswire)
Feb-26-26 10:33PM	Q4 Earnings Recap: CarMax (NYSE:KMX) Tops Vehicle Retailer Stocks (StockStory)
Feb-25-26 10:10AM	Trump Trade: FedEx files suit to recoup tariff duties (TipRanks)
Feb-23-26 07:45PM	CarMax to pay $420K to resolve DOJ allegations over servicemember vehicle repossessions (Fox Business)
Feb-19-26 08:12PM	CarGurus Q4 Earnings Call Highlights (MarketBeat)
Feb-18-26 12:25PM	Why Is CarMax (KMX) Stock Soaring Today (StockStory) +8.05%
Feb-14-26 02:26PM	Carvana Drops 15% This Week: Heres The 3 Biggest Storylines (24/7 Wall St.)
Feb-13-26 08:56AM	$1 Billion Accounting Questions Cloud Carvanas 44% Sales Surge (24/7 Wall St.)
Feb-12-26 09:43AM	CarMax Taps Former Hotel CEO Keith Barr After Sales Slump (Transport Topics) -10.57%
09:00AM	Wallace Weitz Exits CarMax Inc, Impacting Portfolio by -1.58% (GuruFocus.com)
09:00AM	Eclipse backs all-EV marketplace Ever in $31M funding round (TechCrunch)
07:36AM	CarMax Names a New CEO. He's Not a Car Guy. (Barrons.com)
06:50AM	CarMax Names Keith Barr as Chief Executive Officer (Business Wire)
06:20AM	CarMax Taps Hotel Veteran to Lead Turnaround (The Wall Street Journal)
Feb-08-26 11:41PM	1 Safe-and-Steady Stock Worth Investigating and 2 We Question (StockStory)
Feb-04-26 07:30AM	CarMax Named One of TIME's America's Most Iconic Companies (GlobeNewswire)
05:44AM	CarMax, Inc. (KMX) Turns to Pricing and Marketing Actions to Revitalize Sales (Insider Monkey)
Feb-03-26 11:35PM	1 Profitable Stock to Target This Week and 2 We Turn Down (StockStory)
Jan-30-26 09:24AM	Giverny Capital Asset Management Exited Its Long-Term Holding CarMax (KMX) in 2025 (Insider Monkey)
Jan-23-26 08:56AM	Should You Hold CarMax (KMX)? (Insider Monkey)
Jan-14-26 07:50AM	CarGurus Pivots Beyond Marketplace at Needham Conference, Ramping AI and Dealer Software Push (MarketBeat)
Jan-13-26 11:05PM	3 Reasons KMX is Risky and 1 Stock to Buy Instead (StockStory)
Jan-12-26 11:43AM	Why CarMax Stock Slipped 53% In 2025 (Motley Fool)
Jan-07-26 05:59AM	CarMax promises price relief for used-car customers (Wards Auto) +5.35%
Dec-31-25 09:51AM	Here's Why You Should Offload CarMax Stock From Your Portfolio (Zacks)
Dec-26-25 09:16AM	Can Carvana Stock Extend Its Strong 2025 Rally Into 2026? (Zacks)
Dec-25-25 12:31AM	The 5 Most Interesting Analyst Questions From CarMax's Q4 Earnings Call (StockStory)
Dec-22-25 08:59AM	Bear of the Day: CarMax (KMX) (Zacks)
03:34AM	CarMax, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - KMX (PR Newswire)
Dec-20-25 10:00AM	3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500 (MarketBeat)
Dec-19-25 07:38AM	CarMax Q3 Earnings Surpass Expectations, Revenues Decline Y/Y (Zacks)
12:30AM	KMX Q4 Deep Dive: Margin Reset and Leadership Transition Dominate CarMax's Strategy (StockStory)
Dec-18-25 04:18PM	Stocks to Watch Thursday: Trump Media, Micron, Lululemon, Accenture (The Wall Street Journal)
04:01PM	CarMax Inc (KMX) Q3 2026 Earnings Call Highlights: Navigating Sales Decline and Strategic ... (GuruFocus.com)
12:57PM	CarMax Cutting Prices to Draw Car Shoppers Back (The Wall Street Journal)
12:36PM	CarMax Crashes into a Sales Slump as Amazon Circles the Used-Car Lot (GuruFocus.com)
11:53AM	These Stocks Are Moving the Most Today: Micron, DJT, Accenture, Tilray, Lululemon, Medline, Rivian, and More (Barrons.com)
10:49AM	CarMax Scores an Earnings Beat. The Stock Barely Moves. (Barrons.com)
10:46AM	Stock Market Today: Indexes Rise; Nvidia, Tesla Rally But Some Electronics Firms Struggle (Live Coverage) (Investor's Business Daily)
10:15AM	Stock Market Today: Dow, Small Caps Rise On Surprise Inflation Data; Nvidia, Tesla Rally (Live Coverage) (Investor's Business Daily)
09:37AM	Stock Market Today: Dow Rises On Surprise Inflation Data; Nvidia, Tesla Rally (Live Coverage) (Investor's Business Daily)
09:30AM	CarMax (KMX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:00AM	CarMax (KMX) Q3 Earnings and Revenues Top Estimates (Zacks)
07:40AM	CarMax flags lower margins, higher marketing spend; shares slide (Investing.com)
07:18AM	CarMax Beats Earnings Expectations. Why the Stock Is Falling. (Barrons.com)
07:16AM	CarMax Profit Sinks as Struggles Continue (The Wall Street Journal)
07:13AM	CarMax (NYSE:KMX) Beats Q4 CY2025 Sales Expectations (StockStory)
07:00AM	CarMax: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
06:50AM	CarMax Reports Third Quarter Fiscal Year 2026 Results (Business Wire)
05:33AM	Nike headlines Thursday's earnings slate (MarketWatch)
04:24AM	Stock Market Today: S&P 500 and Dow strive to break 4-day losing streak, Nasdaq called higher as Micron results lift tech sentiment; CPI inflation data due; Nike earnings on tap. (MarketWatch)
03:26AM	FedEx, Nike Earnings; Inflation Report: Still to Come This Week (The Wall Street Journal)
Dec-17-25 07:00PM	November CPI, Nike earnings, mortgage rates: What to Watch (Yahoo Finance Video)
Dec-16-25 10:34PM	Spotting Winners: CarMax (NYSE:KMX) And Vehicle Retailer Stocks In Q3 (StockStory)
10:01PM	CarMax Earnings: What To Look For From KMX (StockStory)
Dec-15-25 12:48PM	Reddit Investors Have No Faith in Used Car Stocks \| CVNA CARS CARG (24/7 Wall St.)
11:20AM	Tesla Owner Regrets Thinking His EV Was An 'Investment'Says He's 'Genuinely Shocked At How Much These Things Are Tanking' After Losing $750 A Month (Benzinga)

CarMax, Inc. is a holding company, which engages in the retail of used vehicles and wholesale of vehicle auction operators. It operates through the CarMax Sales Operations and CarMax Auto Finance (CAF) segments. The CarMax Sales Operations segment consists of all aspects of its auto merchandising and service operations. The CAF segment pertains to its finance operation, which offers vehicle financing services to customers buying retail vehicles. The company was founded by Richard L. Sharp and William Austin Ligon in 1993 and is headquartered in Richmond, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McCreight David W.	Director	Mar 16 '26	Option Exercise	41.71	30,558	1,274,574	47,257	Mar 18 04:11 PM
ONeil Mark F	Director	Oct 02 '25	Buy	46.21	10,816	499,807	24,690	Oct 06 04:11 PM
STEENROD MITCHELL D	Director	Oct 02 '25	Buy	45.57	2,000	91,140	38,330	Oct 03 04:09 PM
Daniels Jon G	EVP, CAF	Jul 02 '25	Sale	70.64	1,540	108,786	2,779	Jul 03 04:11 PM
JON DANIELS	Officer	Jul 02 '25	Proposed Sale	70.64	1,540	108,790		Jul 02 04:27 PM

PFE

Pfizer Inc

KMX

Carmax Inc

Upgrade your Finviz experience